Esophageal squamous cell carcinoma (ESCC) is a highly aggressive malignancy with poor prognosis, and understanding the ...
In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.
A new study from the Kowalinski group at EMBL Grenoble characterized the structure of an important trypanosomal protein ...
It is designed to enable targeted muscle tissue delivery with the goal of reducing toxic DMPK RNA in the nucleus, releasing splicing proteins, allowing normal mRNA processing and translation of normal ...
The final, formatted version of the article will be published soon. Background. Splicing is the molecular mechanism to produce mature messenger RNA (mRNA) before its translation into protein. It is ...
What about an mRNA vaccine for H5N1? There isn't one yet, but several companies—including Moderna, Pfizer and GlaxoSmithKline (in collaboration with CureVac)—are working on such a shot.
In this article, we are going to take a look at where Moderna Inc. (NASDAQ:MRNA) stands against other firms end 2024 stronger with impressive gains. A lackluster trading persisted throughout the ...
aMaimonides Institute for Biomedical Research of Cordoba (IMIBIC), Córdoba, Spain. bUniversidad de Córdoba, Córdoba, Spain. cReina Sofia University Hospital, Córdoba, Spain. dCIBER Fisiopatología de ...